XML 146 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Interim Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Analysis of income and expense [abstract]          
General and administrative expenses $ 18,656 $ 7,248 [1] $ 12,729 $ 16,567 $ 2,723
Research and development expenses, net 1,640 1,689 3,059 2,711 1,898
Amortization 2,075      
Selling and marketing expenses 1,380 319 [1] 992 661 569
Impairment and amortization     11,085
Listing expenses     16,802
Operating loss (23,751) (9,256) (27,865) (36,741) (5,190)
Finance expenses 10,724 3,232 13,493 7,891 1,128
Finance income 9,854 1,602 5,957 1,580 28
Gain from remeasurement of investment in associated company     22,164
Share of net profit (loss) of associated companies     (101) 106
Loss before income tax (24,621) (10,886) (35,401) (20,989) (6,184)
Income tax
Net loss (24,621) (10,886) (35,401) (20,989) (6,184)
Other comprehensive loss:     (1,265) (283) (760)
Total comprehensive loss     (36,666) (21,272) (6,944)
Net loss attributable to:          
Equity holders of the Company (23,638) (10,693) (31,092) (20,914)
Non- controlling interest $ (983) $ (193) $ (4,309) $ (75)
Loss per share attribute to the shareholders          
Basic loss per share attributable to shareholders $ (18,219) [1],[2] $ (2,028,889) [3] $ (620,839) [4] $ (41,553,970) [4] $ (44,922,903) [4],[5]
Diluted loss per share attributable to shareholders $ (18,219) [1],[2] $ (2,028,889) [2],[3] $ (620,839) [4],[6] $ (41,553,970) [4],[6] $ (44,922,903) [4],[5],[6],[7]
Other comprehensive loss $ (1,691) $ 92 $ (1,265) $ 63 $ (760)
Total comprehensive loss $ (26,312) $ (10,794) $ (36,666) $ (20,926) $ (6,944)
[1] Reclassification
[2] The share and per share information in these financial statements reflects the 1-for-75, 1-for-28.5, 1-for-4.1, 1-for-7, 1-for-10.89958 and 1-for-8 reverse share splits became effective on, July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025 and November 18, 2025 respectively, of the Company’s issued and outstanding Ordinary Shares (the “Reverse Stock Splits”). See also notes 1.E to 1.H, 9.8 and 9.9
[3] The share and per share information in these financial statements reflects the 1-for-75, 1-for-28.5, 1-for-4.1, 1-for-7, 1-for-10.89958 and 1-for-8 reverse share splits became effective on July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025 and November 18, 2025 respectively, of the Company’s issued and outstanding Ordinary Shares (the “Reverse Stock Splits”) (see also Note 1.E to 1.H, 9.8 and 9.9)
[4] The share and per share information in these financial statements reflects the 1-for-22, 1-for-75, 1-for-28.5, 1-for-4.1, 1-for-7, 1-for-10.89958 and 1-for-8 reverse share splits became effective on August 21, 2023, July 15, 2024, January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025 and November 18, 2025 respectively of the Company’s issued and outstanding Ordinary Shares (the “Reverse Stock Splits”). See also Notes 17.4, 1.F, 1.G, 28.13, 28.14, 28.15 and 28.16.
[5] Restated as a result of the SPAC transaction and after giving effect to the Reverse Stock Splits. See also Note 1.B.
[6] The share and per share information in these financial statements reflects the 1-for-22, 1-for-75, 1-for-28.5, 1-for-4.1 1-for-7, 1-for-10.89958 and 1-for-8 reverse share splits became effective on August 21, 2023, July 15, 2024,  January 15, 2025, June 16, 2025, August 7, 2025, October 23, 2025 and November 18, 2025 respectively, of the Company’s issued and outstanding Ordinary Shares (the “Reverse Stock Splits”). See also notes 17.4, 1.F, 1.G, 28.13, 28.14, 28.15 and 28.16
[7] Restated as a result of the SPAC transaction and after giving effect to the Reverse Stock Splits. See also note 1.B.